🏛️ Verified NIH Record • Updated 2024-05-12
Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis (NCT06417710)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University of Zurich
🩺 Plain-English Summary (8th-Grade Level)
The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.
Who can join: Review the eligibility criteria below.
Location: MD Anderson Cancer Center — Houston, Texas
Age range: 18 Years
🧪 Interventions in This Study
- Neurological Assessment (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- MD Anderson Cancer Center — Houston, Texas
- Netherlands Cancer Institute — Amsterdam,
- University Hospital Zurich — Zurich,
📞 Contact the Study Coordinator
Phone: (832) 837-9347
Email: BJOBrien@mdanderson.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Leptomeningeal Metastasis
- Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases — Chicago, Illinois
- Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis — New York, New York
- BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies — Miami, Florida
- Wearable-Triggered Digital Safety Net for Real-Time Monitoring & Intervention in Leptomeningeal Metastasis — Cleveland, Ohio
- Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases — San Antonio, Texas
Explore by condition: All Leptomeningeal Metastasis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.